Akili plans to go public as it prepares to market video game treatment

“We’ve proven that foundation and now it’s time to run and scale,” CEO Eddie Martucci told MedTech Dive. The company is going public through a $1 billion SPAC, rather than a traditional IPO, expected to close in mid-2022.